09
Feb
Feb
Sure, who wouldn’t want to lose a few pounds? But what’s really driving Hollywood’s latest trend is the drug’s seemingly miraculous side benefits…Read More
Author Archives: Anthony Schewe
sales, Zepbound
Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup
09
Feb
Feb
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite missing the company’s initial sales expectations. Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe proposed by U.S. President Donald…Read more…Read More
09
Feb
Feb
Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy doubled in the fourth quarter, but the Danish pharmaceutical giant warns that sales growth for all its drugs — including Ozempic — is expected to slow in the coming year.Read more…Read More
29
Jan
Jan
Ozempic liver function You don’t have permission to access “http://www.medpagetoday.com/nephrology/diabetes/113985” on this server. Reference #18.351dc917.1738110839.6941054 https://errors.edgesuite.net/18.351dc917.1738110839.6941054 Read More
